Across TCGA pan-cancer cohorts, OR4F1P RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated OR4F1P data layer.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher OR4F1P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR4F1P expression acts as an unfavorable survival marker.
KIRC and LIHC are the cancer types where OR4F1P RNA most reproducibly stratifies survival.